High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study.

Deng, Qiaoling; Ye, Guangming; Pan, Yunbao; Xie, Wen; Yang, Gui; Li, Zhiqiang; Li, Yirong

Deng, Qiaoling; Ye, Guangming; Pan, Yunbao; Xie, Wen; Yang, Gui; Li, Zhiqiang; Li, Yirong.

Afiliação

Deng Q; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Ye G; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Pan Y; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Xie W; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Yang G; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Li Z; Department of Neurosurgery, Zhongnan Hospital, Wuhan University, Wuhan, China.
Li Y; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.

Front Med (Lausanne) ; 8: 676560, 2021.

Article em En | MEDLINE | ID: mdl-34336884

Palavras-chave

COVID-19; SARS-CoV-2N protein antigen; chemiluminescence immunoassay; diagnostic performances; testing strategies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google